In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...